Hong Kong stocks surging: Stone Pharmaceutical-B (02616.HK) jumped nearly 5% at the end of trading day. CS5007 global multicenter phase I clinical trial launched, executives' increase in holdings demonstrates development confidence.
According to the Wise Finance and Economics APP, CSPC Pharmaceutical Group Ltd. - B (02616.HK) rose nearly 5% in the closing session, up 4.26% as of the time of writing, trading at HK$4.65, with a turnover of HK$36.4976 million.
Latest
